---  
layout: startup_page  
title: "Allink Biotherapeutics"  
id: "allinkbio.com"  
permalink: "/allinkbiotherapeuticsallinkbio.com11282024/"  
website: "https://www.allinkbio.com/"  
funding_round: "Series A"  
funding_amount: "$42M"  
investors: "Lanchi Ventures, Yuanbio Venture Capital, Legend Capital, C&D Emerging Industry Equity Investment, Gaorong Ventures, Med-Fine Capital"  
about: "Allink Biotherapeutics is a clinical-stage biotechnology company developing next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics for oncology and immunology diseases. The company focuses on creating First-in-Class (FIC) and Best-in-Class (BIC) therapeutics to address critical unmet medical needs globally. Their innovative platforms are driving the development of a diverse pipeline of promising drug candidates."  
markets: "Biotechnology, Oncology, Immunology, Drug Discovery"  
hq: "Shanghai, China"  
founded_year: "2023"  
linkedin: "https://www.linkedin.com/company/allinkbio"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/allink-biotherapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/539772-67"  

date_display: "28-Nov-2024"  
date: "2024-11-28"

# SEO Optimization  
meta_title: "Allink Biotherapeutics - Series A Funding ($42M)"  
meta_description: "Allink Biotherapeutics, Allink Biotherapeutics is a clinical-stage biotechnology company developing next-generation bispecific antibody and antibody-drug conjugate (ADC) ther..."  
meta_keywords: "Allink Biotherapeutics, Biotechnology, Oncology, Immunology, Drug Discovery, Series A funding"  
canonical_url: "https://startup.projectstartups.com/allinkbiotherapeuticsallinkbio.com11282024/"  
---